Drug intelligence / Profile preview

Qingre Lishi Huayu Fang

Development stage: Preclinical
Lead developer: Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine

Overview

Qingre Lishi Huayu Fang is a traditional Chinese medicine formula being investigated for its therapeutic effects. The name translates to "Clearing Heat, Resolving Dampness, and Dispelling Stasis Formula," indicating its intended actions based on traditional Chinese medicine principles. It is currently undergoing clinical trials for the treatment of Sequelae of pelvic inflammatory disease (SPID) of the damp-heat stasis type.

Other names: 清热利湿化瘀方

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)HSP90AA1 (Heat shock protein HSP90-alpha)JUN (Transcription factor Jun)STAT3 (Signal Transducer and Activator of Transcription 3)VEGFR-1 (Vascular endothelial growth factor receptor 1)VEGFR2 (Vascular endothelial growth factor receptor 2)

Beyond the preview

Go deeper on Qingre Lishi Huayu Fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingre Lishi Huayu Fang.